Diagnostics News and Research

RSS

New research can help explain prevalence of carpal tunnel syndrome and sciatica

New research from the University of Eastern Finland and Kuopio University Hospital can help explain the prevalence of widespread syndromes such as carpal tunnel syndrome and sciatica. According to the results, neural movements can be measured by using non-invasive techniques, which are also applicable in diagnostics and rehabilitation planning.

6 May 2015

Max Planck Institute researchers find protein profiles of DNA repair

During each cell division, more than 3.3 billion base pairs of genomic DNA have to be duplicated and segregated accurately to daughter cells. But what happens when the DNA template is damaged in such a way that the replication machinery gets stuck? To answer this question, scientists in the team of Matthias Mann at the Max Planck Institute of Biochemistry in Martinsried near Munich, with colleagues in Copenhagen and at Harvard, have analyzed how the protein composition of the DNA replication machinery changes upon encountering damaged DNA.

5 May 2015

Novation reports dual-contract award in Bone Densitometry category

Novation today announced its dual-contract award in the Bone Densitometry category. Hologic, Inc. and Swissray International Inc. were both awarded agreements, replacing incumbent GE Healthcare in this category.

4 May 2015

DePuy Synthes, Stryker, Zimmer and Medtronic dominate global orthopedic device market

Kalorama Information said that four companies, including DePuy Synthes, Stryker, Zimmer and Medtronic, lead the Orthopedic Device Market. These four device firms captured approximately 70.4% of total revenues for 2014 for the global orthopedic device market.

30 Apr 2015

CANCER-ID consortium aims to set up standard procedures for clinical validation of blood-based biomarkers

Blood-based biomarkers such as circulating tumor cells (CTCs), circulating free DNA (cfDNA), circulating tumor DNA (ctDNA) and microRNAs (miRNAs) are potential indicators for the tumor burden of patients living with cancer.

30 Apr 2015

New device can turn smartphone into DNA-scanning fluorescent microscope

If you thought scanning one of those strange, square QR codes with your phone was somewhat advanced, hold on to your seat. Researchers at the University of California, Los Angeles have recently developed a device that can turn any smartphone into a DNA-scanning fluorescent microscope.

30 Apr 2015

Papers on antibiotic resistance, neglected diseases and future of the ocean to be discussed during G7 summit

Today the national science academies of the G7 countries handed three statements to their respective heads of government for discussion during the G7 summit at Schloss Elmau in early June 2015. The papers on antibiotic resistance, neglected and poverty-related diseases, and the future of the ocean were drawn up by the seven national academies under the aegis of the German National Academy of Sciences Leopoldina.

30 Apr 2015

Global market for cardiac rhythm management devices worth $13 billion for 2015

The global market for cardiac rhythm management devices such as pacemakers and defibrillators is worth about $13 billion for 2015, according to Kalorama Information. The market research publisher said the market has benefited from the demand to move to a more mobile, wireless and efficient system both within major health facilities and in the home treatment markets. There is also an increasing trend to upgrade to more portable devices and devices which have added benefits such as MRI compatibility.

29 Apr 2015

Researchers discover key mechanism in neural death that causes Parkinson's disease

In studying the molecular biology of brain development, a team of researchers led by Ludwig Stockholm director Thomas Perlmann has discovered how disruption of a developmental mechanism alters the very nerve cells that are most affected in Parkinson's disease.

29 Apr 2015

IDT opens molecular biology R&D facility in Redwood City

Already the world’s leader in custom nucleic acid synthesis, Integrated DNA Technologies (IDT) is capitalizing on its expertise to deliver a broader range of validated molecular biology products. Research and development for these products will now be performed in a newly built facility in Redwood City, California.

From Integrated DNA Technologies 28 Apr 2015

First new treatment authorised in a decade for advanced cervical cancer patients in the UK

The European Commission has licensed Avastin in combination with standard chemotherapy for the treatment of women with advanced cervical cancer. Until now, the treatment has been available ahead of licence to eligible patients in England via individual requests to the Cancer Drugs Fund (CDF).

28 Apr 2015

Luminex provides clinical trial update on ARIES HSV 1&2 Assay

Luminex Corporation today announced that testing at the clinical trial sites for the ARIES HSV 1&2 Assay is now complete. The next steps, including site to site reproducibility testing, followed by data analysis and assembly of the data package for submission to the FDA, are now underway.

From Luminex 28 Apr 2015

PAML signs collaborative agreement with Axela

PAML announced today that the laboratory has entered into a collaborative agreement with Axela, Inc. to develop multiplex assays focused on immune status for vaccine preventable diseases. PAML is one of the nation's leading medical reference laboratories, and Axela focuses on multiplexed nucleic acid and protein analysis for clinical diagnostics.

28 Apr 2015

PCDx test performs better than FoundationOne test in clinical study

Data from a small cohort published OncoTargets and Therapy today shows that the Paradigm Cancer Diagnostic Test (PCDx) performed better than Foundation Medicine's FoundationOne test across a number of key clinical variables, including turnaround time (TAT) and clinically actionable biomarker targets.

28 Apr 2015

Vermillion reports expanded medical policy coverage of OVA1 test

Vermillion, Inc., a bio-analytical solutions company focused on gynecologic disease, today announced expanded medical policy coverage of its OVA1 test, following Blue Cross Blue Shield of Michigan's recent decision to include OVA1 in its medical policy guidelines.

28 Apr 2015

Multichannel Pipette accelerates sample screening and genotyping assays INTEGRA

INTEGRA has published a new customer video from the Institute of Clinical Chemistry research group at the Technical University of Munich (TUM), in which researcher Christina Thomas reviews how the VOYAGER multichannel pipette has accelerated their sample screening and genotyping assays.

From INTEGRA Biosciences 28 Apr 2015

Check-Cap announces Notice of Allowance from USPTO for endoscopy capsule technology

Check-Cap Ltd., a clinical stage medical diagnostics company engaged in the development of a preparation-free ingestible imaging capsule that utilizes low-dose X-rays for the screening for colorectal cancer, today announced receipt of a Notice of Allowance from the United States Patent and Trademark Office for patent application U.S. 13/825,018 entitled, "Estimation of Distances and Size of Lesions in the Colon with an Imaging Capsule."

27 Apr 2015

Merrimack completes submission of MM-398 NDA for treatment of post-gemcitabine metastatic pancreatic cancer

Merrimack Pharmaceuticals, Inc. and Baxter International Inc. today jointly announced that Merrimack has completed the rolling submission of the New Drug Application (NDA) for MM-398 (irinotecan liposome injection), also known as "nal-IRI," to the U.S. Food and Drug Administration.

From Baxter International Inc. 27 Apr 2015

Haemonetics' revenue for fourth quarter fiscal 2015 down 6%

Haemonetics Corporation today reported revenue for the fourth quarter fiscal 2015 of $226.5 million, down 6%. Excluding currency impact, revenue was down 4% in the quarter. The Company reported a fourth quarter GAAP net loss of $2.9 million or $0.06 per share.

27 Apr 2015

Ikonopedia's breast imaging reporting tools, MQSA management system selected for use by BelleBridge

Ikonopedia announced today that its breast imaging reporting tools and MQSA management system have been selected for use by BelleBridge, which provides telemedicine services for interpretations of breast screening and diagnostic examinations.

27 Apr 2015

Diagnostics News and Research

New research can help explain prevalence of carpal tunnel syndrome and sciatica

Max Planck Institute researchers find protein profiles of DNA repair

Novation reports dual-contract award in Bone Densitometry category

DePuy Synthes, Stryker, Zimmer and Medtronic dominate global orthopedic device market

CANCER-ID consortium aims to set up standard procedures for clinical validation of blood-based biomarkers

New device can turn smartphone into DNA-scanning fluorescent microscope

Papers on antibiotic resistance, neglected diseases and future of the ocean to be discussed during G7 summit

Global market for cardiac rhythm management devices worth $13 billion for 2015

Researchers discover key mechanism in neural death that causes Parkinson's disease

IDT opens molecular biology R&D facility in Redwood City

First new treatment authorised in a decade for advanced cervical cancer patients in the UK

Luminex provides clinical trial update on ARIES HSV 1&2 Assay

PAML signs collaborative agreement with Axela

PCDx test performs better than FoundationOne test in clinical study

Vermillion reports expanded medical policy coverage of OVA1 test

Multichannel Pipette accelerates sample screening and genotyping assays INTEGRA

Check-Cap announces Notice of Allowance from USPTO for endoscopy capsule technology

Merrimack completes submission of MM-398 NDA for treatment of post-gemcitabine metastatic pancreatic cancer

Haemonetics' revenue for fourth quarter fiscal 2015 down 6%

Ikonopedia's breast imaging reporting tools, MQSA management system selected for use by BelleBridge

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News